Opioid-induced proliferation of vascular endothelial cells

Journal of Pain Research

Volumn 2, Issue , 2009, Pages 59-66

  Leo, Sandra ^a,b   Nuydens, Rony ^a   Meert, Theo F ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

3 opioid receptor; Angiogenesis; Cell proliferation; Endothelial cells; MAPK; Morphine; Nitric oxide

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; MORPHINE; MU 3 OPIATE RECEPTOR; MU OPIATE RECEPTOR; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; VASCULAR ENDOTHELIUM;

EID: 77953451099     PISSN: None     EISSN: 11787090     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249-257.
2. Rosen LS. Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers. Cancer Control. 2002;9:36-44.
3. Schmidt H, Kirkpatrick J, Kamp G, Wegener G, Peters K. Angiogenesis as a pharmalogical target. G.I.T. Laboratory Journal. 2001;5.
4. Zhang J, Ferguson SS, Barak LS, et al. Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc Natl Acad Sci U S A. 1998;95:7157-7162.
5. Stefano GB, Hartman A, Bilfinger TV, et al. Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J Biol Chem. 1995;270:30290-30293.
6. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J. 2000;351:289-305.
7. Parenti A, Morbidelli L, Cui X-L, et al. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J Biol Biochem. 1998;273:4220-4226.
8. 3 receptor in mammalian microglia, astrocytes and Kupffer cells. Brain Res. 1995;686:239-248.
9. Gupta K, Kshirsagar S, Chang L, et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res. 2002;62:4491-4498.
10. Yu Y, Sato JD. MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor. J Cell Physiol. 1999;178: 235-246.
11. Gille H, Kowalski J, Li B, et al. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem. 2001;276:3222-3230.
12. Schmidt H, Schulz S, Klutzny M, Koch T, Händel M, Höllt V. Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells. J Neurochem. 2000;74:414-422.
13. Lodish H, Baltimore D, Berk A, Zipursky SL, Matsudaira P, Darnell J. Molecular Cell Biology. 4th Edition. New York, NY: W. H. Freeman and Company; 2000.
14. Cobb, 1996.
15. Harrison LM, Kastin AJ, Zadina JE. Opiate tolerance and dependence: Receptors, G-proteins, and antiopiates. Peptides. 1998;19:1603-1630.
16. Law P-Y, Wong YH, Loh HH. Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol. 2000;40:389-430.
17. Papapetropoulos A, Garcia-Cardeña G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest. 1997;100:3131-3139.